Clinical Outcomes of Patients with Metastatic Cancer Receiving Immune Checkpoint Inhibitors in the Inpatient Setting

BACKGROUND: As indications for immune checkpoint inhibitor (ICI) therapy have increased in recent years, so has the proportion of patients eligible for this type of therapy. However, a lack of data exists about the risks and benefits of ICI therapy in hospitalized patients, who tend to be frailer an...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Oncologist
Главные авторы: Durbin, Sienna M., Zubiri, Leyre, Niemierko, Andrzej, Bardia, Aditya, Sullivan, Ryan J., McEwen, Corey, Mulvey, Therese M., Allen, Ian M., Lawrence, Donald P., Cohen, Justine V., Hochberg, Ephraim P., Ryan, David P., Petrillo, Laura A., Reynolds, Kerry L.
Формат: Artigo
Язык:Inglês
Опубликовано: John Wiley & Sons, Inc. 2020
Предметы:
Immuno‐Oncology
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7794195/
https://ncbi.nlm.nih.gov/pubmed/33044765
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/onco.13561
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы